- Home
- ESBA vs LGND Comparison
ESBA vs LGND Comparison
Compare ESBA & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESBA
- LGND
- Stock Information
- Founded
- ESBA N/A
- LGND 1987
- Country
- ESBA United States
- LGND United States
- Employees
- ESBA N/A
- LGND N/A
- Industry
- ESBA
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- ESBA
- LGND Health Care
- Exchange
- ESBA NYSE
- LGND Nasdaq
- Market Cap
- ESBA 2.2B
- LGND 2.0B
- IPO Year
- ESBA 2013
- LGND 1992
- Fundamental
- Price
- ESBA N/A
- LGND $104.97
- Analyst Decision
- ESBA
- LGND Strong Buy
- Analyst Count
- ESBA 0
- LGND 7
- Target Price
- ESBA N/A
- LGND $144.67
- AVG Volume (30 Days)
- ESBA 5.8K
- LGND 127.9K
- Earning Date
- ESBA 01-01-0001
- LGND 05-06-2025
- Dividend Yield
- ESBA 2.02%
- LGND N/A
- EPS Growth
- ESBA N/A
- LGND N/A
- EPS
- ESBA 0.28
- LGND N/A
- Revenue
- ESBA $763,152,000.00
- LGND $167,133,000.00
- Revenue This Year
- ESBA N/A
- LGND $16.47
- Revenue Next Year
- ESBA N/A
- LGND $19.44
- P/E Ratio
- ESBA $24.91
- LGND N/A
- Revenue Growth
- ESBA 3.19
- LGND 27.28
- 52 Week Low
- ESBA $6.39
- LGND $67.72
- 52 Week High
- ESBA $11.50
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- ESBA 35.45
- LGND 47.85
- Support Level
- ESBA $6.70
- LGND $100.30
- Resistance Level
- ESBA $7.07
- LGND $107.62
- Average True Range (ATR)
- ESBA 0.27
- LGND 6.00
- MACD
- ESBA 0.03
- LGND 0.59
- Stochastic Oscillator
- ESBA 40.14
- LGND 74.98
About ESBA EMPIRE STATE REALTY OP LIM PARTNER
Empire State Realty OP LP is an NYC-focused real estate investment trust (REIT) that owns and operates a portfolio of well-leased, top-of-tier, modernized, amenitized, and well-located office, retail, and multifamily assets, conducts all of its business and owns substantially all of its assets. The firm operates in two segments, Real Estate and Observatory. Through the Real Estate segment, it offers services related to the ownership, management, operation, acquisition, repositioning and disposition of its real estate assets. Under the Observatory segment, it operates the two observatories of the Empire State Building. The company generates maximum revenue from the Real Estate segment.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.